Bridgeway Capital Management’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $331K | Hold |
|
|||||
|
2024
Q2 | $274K | Sell |
|
|||||
|
2024
Q1 | $494K | Sell |
|
|||||
|
2023
Q4 | $740K | Buy |
|
|||||
|
2023
Q3 | $486K | Buy |
|
|||||
|
2023
Q2 | $292K | Hold |
|
|||||
|
2023
Q1 | $466K | Hold |
|
|||||
|
2022
Q4 | $521K | Hold |
|
|||||
|
2022
Q3 | $316K | Sell |
|
|||||
|
2022
Q2 | $343K | Buy |
|
|||||
|
2022
Q1 | $431K | Buy |
|
|||||
|
2021
Q4 | $243K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $311K | Buy |
|
|||||
|
2020
Q4 | $27K | Sell |
|
|||||
|
2020
Q3 | $559K | Hold |
|
|||||
|
2020
Q2 | $581K | Buy |
|
|||||
|
2020
Q1 | $228K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $113K | Hold |
|
|||||
|
2019
Q2 | $169K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $72K | Hold |
|
|||||
|
2018
Q2 | $87K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $162K | Hold |
|
|||||
|
2016
Q4 | $366K | Buy |
|
|||||
|
2016
Q3 | $316K | Buy |
|
|||||
|
2016
Q2 | $102K | Buy |
|